ロード中...
Antifibrinolytics for heavy menstrual bleeding
BACKGROUND: Heavy menstrual bleeding (HMB) is an important physical and social problem for women. Oral treatment for HMB includes antifibrinolytic drugs, which are designed to reduce bleeding by inhibiting clot‐dissolving enzymes in the endometrium. Historically, there has been some concern that usi...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2018
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494516/ https://ncbi.nlm.nih.gov/pubmed/29656433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000249.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|